{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:42:19Z","timestamp":1790451739817,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2016-05845"],"award-info":[{"award-number":["RGPIN-2016-05845"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.omtm.2021.03.022","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T20:51:40Z","timestamp":1617051100000},"page":"559-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Testing the efficacy of a human full-length OPG-Fc analog in a severe model of cardiotoxin-induced skeletal muscle injury and repair"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8464-9223","authenticated-orcid":false,"given":"Zineb","family":"Bouredji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dounia","family":"Hamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Marcadet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anteneh","family":"Argaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Frenette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.03.022_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3803\/EnM.2015.30.1.35","article-title":"NF-\u03baB-mediated regulation of osteoclastogenesis","volume":"30","author":"Boyce","year":"2015","journal-title":"Endocrinol. Metab. (Seoul)"},{"key":"10.1016\/j.omtm.2021.03.022_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.03.022_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mce.2014.06.004","article-title":"Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes","volume":"394","author":"Bernardi","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.omtm.2021.03.022_bib4","first-page":"561689","article-title":"GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients","volume":"2013","author":"Tisato","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.omtm.2021.03.022_bib5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ajpath.2015.01.006","article-title":"Osteoprotegerin protects against muscular dystrophy","volume":"185","author":"Dufresne","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2021.03.022_bib6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1515\/CCLM.2009.163","article-title":"Systemic cytokine response following exercise-induced muscle damage in humans","volume":"47","author":"Philippou","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.omtm.2021.03.022_bib7","doi-asserted-by":"crossref","first-page":"10072","DOI":"10.1038\/s41598-018-28117-2","article-title":"Angiogenin and osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines","volume":"8","author":"Rutti","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2021.03.022_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/hmg\/ddz312","article-title":"Muscle weakness and selective muscle atrophy in osteoprotegerin-deficient mice","volume":"29","author":"Hamoudi","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.03.022_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1051\/medsci\/20163206022","article-title":"[Inflammation and regeneration, a double-edged sword]","volume":"32","author":"Dufresne","year":"2016","journal-title":"Med. Sci. (Paris)"},{"key":"10.1016\/j.omtm.2021.03.022_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/mus.10453","article-title":"Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom","volume":"28","author":"Teixeira","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2021.03.022_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1600-065X.2000.17706.x","article-title":"The neutrophil as a cellular source of chemokines","volume":"177","author":"Scapini","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.omtm.2021.03.022_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2007-1000152","article-title":"Selective neutrophil depletion with monoclonal antibodies attenuates ischemia\/reperfusion injury in skeletal muscle","volume":"14","author":"Iwahori","year":"1998","journal-title":"J.\u00a0Reconstr. Microsurg."},{"key":"10.1016\/j.omtm.2021.03.022_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/B978-0-12-417028-5.00006-5","article-title":"Macrophage activation and polarization as an adaptive component of innate immunity","volume":"120","author":"Locati","year":"2013","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.omtm.2021.03.022_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/JES.0b013e318190ebdb","article-title":"Dual and beneficial roles of macrophages during skeletal muscle regeneration","volume":"37","author":"Chazaud","year":"2009","journal-title":"Exerc. Sport Sci. Rev."},{"key":"10.1016\/j.omtm.2021.03.022_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4049\/jimmunol.175.1.342","article-title":"Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences","volume":"175","author":"Stout","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2021.03.022_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-018-0533-1","article-title":"Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy","volume":"6","author":"Dufresne","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.omtm.2021.03.022_bib17","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1093\/hmg\/ddz124","article-title":"An anti-RANKL treatment reduces muscle inflammation and dysfunction and strengthens bone in dystrophic mice","volume":"28","author":"Hamoudi","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.03.022_bib18","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.str.2012.08.030","article-title":"RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor","volume":"20","author":"Nelson","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.omtm.2021.03.022_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cytogfr.2013.06.001","article-title":"Osteoprotegerin: Multiple partners for multiple functions","volume":"24","author":"Baud\u2019huin","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.omtm.2021.03.022_bib20","doi-asserted-by":"crossref","first-page":"20959","DOI":"10.1074\/jbc.C000290200","article-title":"Osteoprotegerin is an \u03b1v\u03b23-induced, NF-\u03baB-dependent survival factor for endothelial cells","volume":"275","author":"Malyankar","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2021.03.022_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mvr.2008.06.004","article-title":"Role of \u03b1v integrin in osteoprotegerin-induced endothelial cell migration and proliferation","volume":"76","author":"Kobayashi-Sakamoto","year":"2008","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.omtm.2021.03.022_bib22","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1210\/jc.2004-1895","article-title":"Syndecan-1 is involved in osteoprotegerin-induced chemotaxis in human peripheral blood monocytes","volume":"90","author":"Mosheimer","year":"2005","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2021.03.022_bib23","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1096\/fj.10-170449","article-title":"\u03b23-integrin mediates satellite cell differentiation in regenerating mouse muscle","volume":"25","author":"Liu","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2021.03.022_bib24","doi-asserted-by":"crossref","first-page":"e60445","DOI":"10.7554\/eLife.60445","article-title":"Myogenin is an essential regulator of adult myofibre growth and muscle stem cell homeostasis","volume":"9","author":"Ganassi","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.omtm.2021.03.022_bib25","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20070075","article-title":"Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis","volume":"204","author":"Arnold","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2021.03.022_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nri.2016.150","article-title":"Regulation of muscle growth and regeneration by the immune system","volume":"17","author":"Tidball","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtm.2021.03.022_bib27","doi-asserted-by":"crossref","first-page":"e0147198","DOI":"10.1371\/journal.pone.0147198","article-title":"Comparative study of injury models for studying muscle regeneration in mice","volume":"11","author":"Hardy","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2021.03.022_bib28","doi-asserted-by":"crossref","first-page":"R651","DOI":"10.1152\/ajpregu.00069.2007","article-title":"Delayed angiogenesis and VEGF production in CCR2\u2212\/\u2212 mice during impaired skeletal muscle regeneration","volume":"293","author":"Ochoa","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.omtm.2021.03.022_bib29","doi-asserted-by":"crossref","first-page":"B43","DOI":"10.1093\/gerona\/51A.1.B43","article-title":"The regeneration of noninnervated muscle grafts and marcaine-treated muscles in young and old rats","volume":"51","author":"Carlson","year":"1996","journal-title":"J.\u00a0Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.omtm.2021.03.022_bib30","first-page":"R166","article-title":"Acute phase response in exercise. III. Neutrophil and IL-1 \u03b2 accumulation in skeletal muscle","volume":"265","author":"Fielding","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.omtm.2021.03.022_bib31","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4049\/jimmunol.1801228","article-title":"Azithromycin polarizes macrophages to an M2 phenotype via inhibition of the STAT1 and NF-\u03baB signaling pathways","volume":"203","author":"Haydar","year":"2019","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2021.03.022_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0041-0101(93)90376-T","article-title":"Cardiotoxin 1 from cobra (Naja naja atra) venom causes necrosis of skeletal muscle in\u00a0vivo","volume":"31","author":"Ownby","year":"1993","journal-title":"Toxicon"},{"key":"10.1016\/j.omtm.2021.03.022_bib33","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1152\/jappl.2001.91.2.534","article-title":"Myogenic satellite cells: Physiology to molecular biology","volume":"91","author":"Hawke","year":"2001","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.omtm.2021.03.022_bib34","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2021.03.022_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1242\/jcs.00828","article-title":"Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: Requirement of syndecan-3 for successful fiber formation","volume":"117","author":"Casar","year":"2004","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.omtm.2021.03.022_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13395-015-0046-6","article-title":"Developmental myosins: expression patterns and functional significance","volume":"5","author":"Schiaffino","year":"2015","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtm.2021.03.022_bib37","doi-asserted-by":"crossref","first-page":"R1508","DOI":"10.1152\/ajpregu.00486.2005","article-title":"Expression of slow myosin heavy chain during muscle regeneration is not always dependent on muscle innervation and calcineurin phosphatase activity","volume":"290","author":"Launay","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.omtm.2021.03.022_bib38","first-page":"75","article-title":"Targeted ovarian cancer treatment: the TRAILs of resistance","volume":"2","author":"Khaider","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.omtm.2021.03.022_bib39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1757-2215-6-82","article-title":"Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis","volume":"6","author":"Lane","year":"2013","journal-title":"J.\u00a0Ovarian Res."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121000620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121000620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:25:31Z","timestamp":1762421131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050121000620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":39,"alternative-id":["S2329050121000620"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.03.022","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testing the efficacy of a human full-length OPG-Fc analog in a severe model of cardiotoxin-induced skeletal muscle injury and repair","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}